REFERENCES
- Schlichter JG, Maclean H. A method of determining the effective therapeutic level in the treatment of subacute bacteri-al endocarditis with penicillin. A preliminary report. Am Heart J 1947; 34: 209–211.
- Weinstein MP, Stratton CW, Ackley A, et al. Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med 1985; 78 (2): 262–269.
- Weinstein MP, Stratton CW, Hawley HB, Ackley A, ReIler LB. Multicenter collaborative evaluation of a standard-ized serum bactericidal test as a predictor of therapeutic effica-cy in acute and chronic osteomyelitis. Am J Med 1987; 83 (2): 218–222.
- Shah PM. Serum bactericidal activity of levofloxacin against Streptococcus pneumoniae. J Antimicrob Chemother 1999; 43 (Suppl C): 61–65.
- Ball P. Bacterial resistance to fluoroquinolones: lessons to be learned. Infection. 1994; 22 (Suppl. 2): S140–147.
- Davies TA, Kelly LM, Pankuch GA, Credito KL, Jacobs MR, Appelbaum PC. Antipneumococcal activities of gemi-floxacin compared to those of nine other agents. Antimicrob Agents Chemother 2000; 44 (2): 304–310.
- Ball P. Quinolone generations: natural history or natural selection? J Antimicrob Chemother 2000; 46 (Suppl Ti): 17–24.
- Brenwald N, Gill MJ, Boswell F, Wise R. Activity of gemifloxacin against S. pneumoniae in strains resistant to flu-oroquinolones by an efflux mechanism. Abstract P477. J Antimicrob Chemother 1999; 44(Suppl. A): 145.
- Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to flu-oroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999; 341 (4): 233–239.
- Ronchetti MP, Merolla R, Bajaksouzian S, Violo G, Ronchetti R, Jacobs MR. Antimicrobial susceptibility of Streptococcus pneumoniae from children attending day-care centers in a central Italian city. Clin Microbiol Infect 1998; 4 (11): 622–626.
- Nilsson P, Laurell MH. Carriage of penicillin-resistant Streptococcus pneumoniae by children in day-care centers during an intervention program in Malmo, Sweden. Pediatr Infect Dis J 2001; 20 (12): 1144–1149.
- Echols R, Weinstein MP, O'Keeffe B, Shah A, Heller AH. Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin. J Antimicrob Chemother 1994; 33 (1): 111–118.
- Prieto J, Aguilar L, Fuentes F, et al. Influence of dimin-ished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers. Int J Antimicrob Agents 2001; 18 (3): 231–238.
- Lemmen S, Al-Lahham A, Ltitticken R, Reinert RR. In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany. Chemotherapy 2001; 47 (2): 104–109.
- Zhanel CC, Roberts D, Waltky A, et al. Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 2002; 49 (5): 807–812.
- Morissey I, George JT. Bactericidal activity of gemi-floxacin and other quinolones against Streptococcus pneumoniae. J Antimicrob Chemother 2002; 45 (Suppl. Si): 107–110.